Mednet Logo
HomeEndocrinology
Endocrinology

Endocrinology

Physician discussions on diabetes management, thyroid disorders, hormonal imbalances, and metabolic conditions.

Recent Discussions

Should Orlistat be considered in the management of hypertriglyceridemia?

1
1 Answers

Mednet Member
Mednet Member
Endocrinology · Mayo Clinic College of Medicine and Science

While there are no controlled trials addressing this issue, it is certainly a reasonable option which I have used in some patients with Familial Chylomicronemia Syndrome. It will help to reduce the generation of chylomicrons and therefore the subsequent risk for hypertriglyceridemic pancreatitis. Ma...

How should very low T scores (worse than -3) be interpreted in very thin patients (BMI < 18)?

2
1 Answers

Mednet Member
Mednet Member
Endocrinology · Boston University School of Medicine

It would be very helpful to know the age of the patients. Age is well documented to be independently inversely related to fracture risk for the same T score. Low BMI places less stress on the skeleton and in response the skeleton maintains lower bone mineral content i.e. bone mineral density. There ...

Should thyroid hormone replacement be initiated in patients with very prolonged critical illness with associated low thyroid hormone levels?

1 Answers

Mednet Member
Mednet Member
Endocrinology · Kaiser Permanente Oakland Medical Center Endocrinology

There is no evidence that LT4 is of benefit in such patients.

Should patients with asymptomatic GH deficiency be treated with GH replacement therapy if they have prior known severe CAD?

1 Answers

Mednet Member
Mednet Member
Endocrinology · Johns Hopkins Endocrinology and Pituitary Center

Yes, GHRT should be discussed with GHD adults independently from symptoms. There is no evidence that GHRT increases the risk of CAD, and in fact, it may be beneficial due to the lowering of total and LDL cholesterol (this is a theoretical benefit, as I am not aware of any study that showed that GHRT...

Does caution have to be used in GH replacement therapy in any and all types of cancer history?

1 Answers

Mednet Member
Mednet Member
Endocrinology · Johns Hopkins Endocrinology and Pituitary Center

In general, GH RT is contraindicated in patients with an ACTIVE malignancy. My practice is not to treat until I have 5 years of cancer-free interval. The situation is different with pituitary adenomas and craniopharyngiomas, as there is literature showing that GHRT does not increase the risk of recu...

Is a significant rise in cortisol post cosyntropin stimulation sufficient to rule out adrenal insufficiency in patients with low albumin?

1 Answers

Mednet Member
Mednet Member
Endocrinology · Johns Hopkins Department Of Endocrinology Diabetes And Metabolism

We use the absolute cortisol (or free cortisol) values rather than the degree of the rise in cortisol as an indicator of normal adrenal function during the ACTH Stimulation Test. Is this question related to the critically ill patients?

Should a short trial of androgen therapy be used in patients with primary adrenal insufficiency suffering from persistent fatigue and hypoactive sexual desire despite sufficient glucocorticoid and mineralocorticoid replacement?

1 Answers

Mednet Member
Mednet Member
Endocrinology · Johns Hopkins Department Of Endocrinology Diabetes And Metabolism

Considering that adrenal glands are an important source of androgens in women, this approach, especially in symptomatic patients, seems reasonable. I usually use DHEA supplements starting at 25 mg daily and then adjust the dose based on the DHEAS and testosterone levels. Most patients require 12.5 t...

Can osilodrostat be used indefinitely in poor surgical candidates with cushing syndrome from adrenal adenoma?

1 Answers

Mednet Member
Mednet Member
Endocrinology · Johns Hopkins Department Of Endocrinology Diabetes And Metabolism

There is no restriction on the duration of therapy with osilodrostat. One of the goals is to improve the clinical condition of the patient, so the patient can become a surgical candidate.

In adult women with NCCAH, is there a benefit in using supratherapeutic doses of prednisone in addition to clomiphene to improve fertility rates?

1 Answers

Mednet Member
Mednet Member
Endocrinology · Johns Hopkins Department Of Endocrinology Diabetes And Metabolism

In NC-CAH, subfertility is mild compared with the classical form. Most women with nonclassic 21-hydroxylase deficiency have normal ovulation and ability to conceive, but miscarriages occur in up to 25% of their pregnancies. In women with NC-CAH who are infertile or have a history of prior miscarriag...

Should testosterone replacement be stopped in elderly men who suffered acute stroke even when testosterone levels have been stably in the low-to-mid normal range?

1 Answers

Mednet Member
Mednet Member
Endocrinology · MGH

Recent data are reassuring with regard to the cardiovascular safety of physiologic testosterone replacement in older men. The TRAVERSE study of 5,246 men 45 to 80 years of age who had preexisting or a high risk of cardiovascular disease and were randomly assigned to a testosterone gel or placebo sho...